GlassScriptPhysician profile
Michael D Richmond
NPI 1689646879
$1,923.39
in general payments reported to CMS, 2019-2025
15 companies · $753 in 2025
The $753 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.24 · 2020: $54.52 · 2022: $150 · 2023: $161 · 2024: $713 · 2025: $753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,626.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $421.24 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $353.31 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $251.31 | 2023-2025 | Repatha, Repatha, Otezla |
| Pfizer INC. | $165.10 | 2023-2025 | |
| Lilly USA, LLC | $131.78 | 2020-2025 | Zepbound, Mounjaro, Kisunla |
| Merck Sharp & Dohme LLC | $122.49 | 2020-2025 | Gardasil 9, Vaxelis, Capvaxive |
| Abbott Laboratories | $81.46 | 2025 | Id Now Instrument |
| Abbvie INC. | $77.21 | 2024-2025 | |
| Exact Sciences Corporation | $72.49 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $61.62 | 2019-2024 | Shingrix |
| Alk-Abello, INC | $57.35 | 2024 | Grastek, Odactra, Ragwitek |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.19 | 2024-2025 | Jardiance |
| Viatris Specialty LLC | $33.33 | 2025 | Yupelri |
| Otsuka America Pharmaceutical, INC. | $25.65 | 2024 | Rexulti |
| Phadia US INC. | $15.86 | 2025 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Richmond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.